Wits Health Consortium (Pty) Ltd
Parktown, Gauteng, South Africa
Purpose
To develop an Escherichia coli Fluidigm assay that provides adequate coverage of the most prevalent colonizing and invasive isolates from neonates in South Africa.
Division
Global Health
Date
October 2025
Region Served
AFRICA
Committed amount
$689,509
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
24
Grantee location
Parktown, Gauteng, South Africa
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.